Pharma Journalist -

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that ZILBRYSQ (zilucoplan) has been approved by the U.S. Food and Drug Administration (FDA) for the…
Read More...

SpliceBio, a genetic medicines company harnessing Protein Splicing to develop the next generation of gene therapies, is pleased to announce the signing of an exclusive collaboration and…
Read More...

Gilead Sciences, Inc. and Assembly Biosciences, Inc. announced that the companies have entered into a 12-year partnership to advance the research and development of novel antiviral…
Read More...

Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, and GlobalBio, Inc. (GlobalBio), an antibody engineering company…
Read More...

LegoChem Biosciences Inc. (LCB) and Glycotope GmbH (Glycotope) have entered into an exclusive worldwide licensing agreement to develop an antibody drug conjugate (ADC) by combining…
Read More...

Novo Nordisk A/S and KBP Biosciences PTE., Ltd. announced that Novo Nordisk has agreed to acquire ocedurenone for uncontrolled hypertension with potential application in cardiovascular…
Read More...

Vaxcyte, Inc., a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, and Lonza, a global…
Read More...

Almirall S.A., a global biopharmaceutical company focused on medical dermatology, today announced the presentation of new data on lebrikizumab through 18 abstracts, including two oral…
Read More...

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) + MEKTOVI (binimetinib) for the treatment of adult patients with metastatic…
Read More...

MimiVax, Inc., a biotechnology company focused on the development of glioblastoma vaccine therapy, announced that the United States Food and Drug Administration (FDA) has granted Fast…
Read More...